Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Affiliations Topics Sessions Videos Audios Previous meetings

Topics

Select Topic

Showing 110 results for "Chronic Lymphocytic Leukemia (CLL)".

Thumbnail for BTK Inhibitors Are Associated With Significantly Lower Hospitalization and Reduced Cardiovascular Morbidity Compared With Venetoclax-Based Regimens in CLL/SLL: A Propensity Score-Matched, Real-World Analysis

CLL - 693

BTK Inhibitors Are Associated With Significantly Lower Hospitalization and Reduced Cardiovascular Morbidity Compared With Venetoclax-Based Regimens in CLL/SLL: A Propensity Score-Matched, Real-World Analysis

Ekow Pinkrah

Poster Presenter: Ekow Pinkrah

Thumbnail for Risk of Tumor Lysis Syndrome (TLS) Among Patients With Chronic Lymphocytic Leukemia (CLL) or Mantle Cell Lymphoma (MCL) Treated With Venetoclax: A Real-World Study

CLL - 737

Risk of Tumor Lysis Syndrome (TLS) Among Patients With Chronic Lymphocytic Leukemia (CLL) or Mantle Cell Lymphoma (MCL) Treated With Venetoclax: A Real-World Study

Alessandra Ferrajoli

Poster Presenter: Alessandra Ferrajoli

Previous 1...8 9 10 11 12 13 Next

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

Thumbnail for Pirtobrutinib's Cardiac Adverse Reactions: An Early Pharmacovigilance Study

CLL - 763

Pirtobrutinib's Cardiac Adverse Reactions: An Early Pharmacovigilance Study

Maroun Ibrahim

Poster Presenter: Maroun Ibrahim

Thumbnail for Micro-Dosed Obinutuzumab: A Novel Debulking Strategy in a Rare Case of Leukostasis From Chronic Lymphocytic Leukemia

CLL - 787

Micro-Dosed Obinutuzumab: A Novel Debulking Strategy in a Rare Case of Leukostasis From Chronic Lymphocytic Leukemia

Ahmed Qaedi

Poster Presenter: Ahmed Qaedi

Thumbnail for Pirtobrutinib in Treatment-Naοve (TN) Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): Pooled Results From BRUIN CLL-313 and BRUIN CLL-314

CLL - 796

Pirtobrutinib in Treatment-Naοve (TN) Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): Pooled Results From BRUIN CLL-313 and BRUIN CLL-314

William G Wierda

Poster Presenter: William G Wierda

Thumbnail for Venetoclax Initiation, Monitoring, and Interventions After Acalabrutinib Lead-In for Chronic Lymphocytic Leukemia

CLL - 823

Venetoclax Initiation, Monitoring, and Interventions After Acalabrutinib Lead-In for Chronic Lymphocytic Leukemia

Emily Lee

Poster Presenter: Emily Lee

Thumbnail for Mortality and Bleeding Tradeoffs Associated With Oral Anticoagulation in BTK Inhibitor-Treated Chronic Lymphocytic Leukemia Patients With Atrial Fibrillation/Flutter: A Propensity-Matched TriNetX Analysis

CLL - 860

Mortality and Bleeding Tradeoffs Associated With Oral Anticoagulation in BTK Inhibitor-Treated Chronic Lymphocytic Leukemia Patients With Atrial Fibrillation/Flutter: A Propensity-Matched TriNetX Analysis

Alexander Mays

Poster Presenter: Alexander Mays

Thumbnail for Infections in Chronic Lymphocytic Leukemia: A National Inpatient Sample Analysis of Prevalence and Mortality

CLL - 864

Infections in Chronic Lymphocytic Leukemia: A National Inpatient Sample Analysis of Prevalence and Mortality

Rabia Iqbal

Poster Presenter: Rabia Iqbal

Thumbnail for Clinical Outcomes Among Anticoagulated Patients with CLL and Atrial Fibrillation/Flutter Treated with First- Versus Second-Generation BTK Inhibitors

CLL - 868

Clinical Outcomes Among Anticoagulated Patients with CLL and Atrial Fibrillation/Flutter Treated with First- Versus Second-Generation BTK Inhibitors

Nnamdi Omenuko

Poster Presenter: Nnamdi Omenuko

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors